1                                              McCune-Albright syndrome (MAS) is a mosaic disorder aris

2                                              McCune-Albright syndrome (MAS), a mosaic condition assoc

3     Recently, IPMNs have been described as a McCune-Albright syndrome-associated tumor, present in ab

4 CDKN2A and from induced hPSCs derived from a McCune-Albright patient.

5  patients with fibrous dysplasia of bone and McCune-Albright syndrome generated more basal cAMP accum

6 valence of polyostotic fibrous dysplasia and McCune-Albright syndrome among patients operated on for

7  the cause of fibrous dysplasia of bone (FD)/McCune-Albright syndrome (MAS).

8 ction mutations) and hormone hypersecretion (McCune-Albright syndrome caused by gain-of-function muta

9  papillary mucinous neoplasms (IPMNs) and in McCune-Albright syndrome, characterized by fibrous dyspl

10  heterotrimeric G-protein disorders, joining McCune-Albright and Sturge-Weber syndromes.

11 dromes predisposing to pituitary neoplasias: McCune-Albright syndrome, multiple endocrine neoplasia t

12 evidence of a syndromic IPMN as a feature of McCune-Albright syndrome, this observation is further ev

13  spots on clinical examination suggestive of McCune-Albright syndrome.

14 strogen receptor (ER) was described by Smith-McCune et al.

15 olyostotic fibrous dysplasia, and 26 had the McCune-Albright syndrome.

16  dysplasia of bone is a major finding in the McCune-Albright syndrome.

17           Because of its similarities to the McCune-Albright syndrome and other features, such as par

18 sodes and bone age advancement in girls with McCune-Albright syndrome (MAS), despite ovarian enlargem

19 scintigraphy was performed on a patient with McCune-Albright syndrome and acromegaly.

20 yclase have been identified in patients with McCune-Albright syndrome, but the mechanism leading to t

21 ucinous tumors are observed in patients with McCune-Albright syndrome.